Cardiovascular disease, Hypertension, diabetes, dyslipidemia. Abnormal result of cardiovascular function study, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Willingness to participate in the study Age between 20-75 years Having at least one of cardiovascular disease risk factors (including diabetes, dyslipidemia, hypertension, smoking )
Exclusion criteria
Exclusion criteria: having BMI>30 Patients on nitrate or anticoagulant drugs Regular consumption (more than once in a week) of vitamins or minerals supplements during past month Chronic kidney disease stage 4 or 5 pregnancy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Flow mediated dilation (FMD). Timepoint: Baseline and the end of the study. Method of measurement: sonography. | — |
Secondary
| Measure | Time frame |
|---|---|
| Plasma ICAM-1. Timepoint: Baseline and the end of the study. Method of measurement: ELISA.;Plasma VCAM-1. Timepoint: Baseline and the end of the study. Method of measurement: ELISA. | — |
Countries
Iran (Islamic Republic of)
Contacts
Artesh University of Medical Sciences